The dominant model demonstrated SNPs at the CDKN2A loci, a gene coding for a cyclin-dependent kinase inhibitor 2A, were highly associated with an increased risk of GDM in Japanese participants. This evidence concerns the gene CDKN2A and gestational diabetes.